Vanquish Oncology, Inc. — Form D/A
Vanquish Oncology, Inc. of CHAMPAIGN, IL, a company, filed a Form D amendment with the SEC on 2014-04-10. The offering totals $4.8M, of which $4.4M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2014-04-10
- Form: D/A
- Accession: 0001572746-14-000001
- Industry: Biotechnology
- Exemptions: 06b, 4a5
- Total offering: $4.8M
- Amount sold: $4.4M
- Remaining: $389K
- Minimum investment: $25K
- Investors: 3
- Date of first sale: 2013-03-18
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-193863
Issuer
- Name: Vanquish Oncology, Inc.
- CIK: 0001572746
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: 2001 S. FIRST ST., CHAMPAIGN, IL, 61820
- Phone: 510-219-6200
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Ted Tarasow | Director | Champaign, IL |
| Ted Tarasow | Executive Officer | Champaign, IL |
| Billie Jo Herberger | Director | Champaign, IL |
| Paul Hergenrother | Director | Champaign, IL |
| Paul Hergenrother | Executive Officer | Champaign, IL |
| Judd Herberger | Director | Champaign, IL |
| Ron Way | Director | Champaign, IL |
| Judd Heberger | Director | Champaign, IL |
Other filings by this issuer (4)
More